Cargando…
Granulocyte Colony-Stimulating Factor Treatment During Radiotherapy Is Associated With Survival Benefit in Patients With Lung Cancer
OBJECTIVES: Granulocyte colony-stimulating factor, an agent commonly used for neutropenia treatment, plays an important role in cancer treatment. However, the effect of granulocyte colony-stimulating factor treatment on patient’s survival during radiation therapy in lung cancer remains unknown. MATE...
Autores principales: | Du, Rui, Hu, Pingping, Liu, Qiqi, Zhang, Jingxin, Deng, Guodong, Hu, Dan, Zhang, Jiandong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295692/ https://www.ncbi.nlm.nih.gov/pubmed/31122176 http://dx.doi.org/10.1177/1533033818816076 |
Ejemplares similares
-
Elevated serum granulocyte-macrophage colony-stimulating factor levels during radiotherapy predict favorable outcomes in lung and esophageal cancer
por: Deng, Guodong, et al.
Publicado: (2016) -
Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer
por: Zhang, Jingxin, et al.
Publicado: (2017) -
The protective effects of granulocyte-macrophage colony-stimulating factor against radiation-induced lung injury
por: Hu, Dan, et al.
Publicado: (2020) -
Radiotherapy programs neutrophils to an antitumor phenotype by inducing mesenchymal-epithelial transition
por: Liu, Qiqi, et al.
Publicado: (2021) -
Genomic analysis of the prognostic value of colony-stimulating factors (CSFs) and colony-stimulating factor receptors (CSFRs) across 24 solid cancer types
por: Huang, Xinyi, et al.
Publicado: (2020)